# Davide Turco > Davide Turco is a seed investor at Indaco Venture Partners backing Biotechnology and Hardware. See 13 investments, check sizes, portfolio. Updated Aug 2026. - Type: Angel Investor - Fund: [Indaco Venture Partners](https://shizune.co/investors/profile/indaco-venture-partners) - Location: Milano, Italy - Total investments: 13 - Last investment: Feb 2025 - Lead investor: 15% - Last updated: Aug 2026 - LinkedIn: http://www.linkedin.com/pub/davide-turco/7/794/a7a Davide Turco is a seed investor at Indaco Venture Partners in Milano focused on Biotechnology and Hardware. Davide Turco joined Indaco Venture Partners as Co-Founder & Managing Director. ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Biotechnology | 3 | 23% | | Hardware | 1 | 8% | | Hospital | 1 | 8% | | Software | 1 | 8% | | Health Care | 1 | 8% | 10 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Seed | 2 | 15% | | Series B | 2 | 15% | | Funding Round | 2 | 15% | | Series A | 1 | 8% | ### Country | Country | Investments | Share | | --- | --- | --- | | Italy | 3 | 23% | | Switzerland | 1 | 8% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Newronika | Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies. | $14.2M | Series B | Feb 13, 2025 | | | TES Pharma | TES Pharma is a research-based biopharmaceutical company focusses on delivering first in class preclinical candidates that unlock the potential of novel therapeutic targets and mechanisms. | $5.2M | Series A | Dec 19, 2024 | | | MicThera | MicThera focuses on developing microbial-derived therapeutics to provide effective treatments for prostate cancer patients, aiming to find effective solutions for medical companies. | $1.1M | Seed | May 30, 2024 | | | WISE | WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | $7.1M | Series B | May 25, 2017 | | | WISE | WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | $3.3M | Series A | Jun 09, 2015 | | | WISE | WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | $3.3M | Series A | Jun 09, 2015 | | | WISE | WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | | | Jul 11, 2014 | | | Tethis S.p.A | Tethis is a bio- and nanotechnology company. | | | Feb 28, 2014 | | | WISE | WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | | Seed | Nov 08, 2013 | | | WISE | WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | | | May 11, 2013 | | 10 of 13 investments shown. ## Co-investors - [Principia SGR](https://shizune.co/investors/profile/quantica-sgr) — VC Fund, 5 deals together - [F3F](https://shizune.co/investors/profile/f3f) — VC Fund, 3 deals together - [Agite!](https://shizune.co/investors/profile/agite) — VC Fund, 2 deals together - [Amigdala](https://shizune.co/investors/profile/amig-dala) — VC Fund, 2 deals together - [Antares Capital](https://shizune.co/investors/profile/antares-capital) — VC Fund, 2 deals together - [b2venture](https://shizune.co/investors/profile/btovpartners) — VC Fund, 2 deals together ## About Indaco Venture Partners VC Fund · Milan, Italy Indaco Venture Partners is an asset management company that invests in the technology, electronics, medtech, and materials sectors. 5 contacts available at Indaco Venture Partners. | Name | Title | Profile | | --- | --- | --- | | Alvise Bonivento | Co-Founder, Investment Director & Board Member | https://shizune.co/investors/profile/alvise-bonivento-56f4 | | Antonella Beltrame | Partner | https://shizune.co/investors/profile/antonella-beltrame | | Cosimo Calcagno | Investment Manager | https://shizune.co/investors/profile/cosimo-calcagno | | Davide Turco | Managing Director and Founder | https://shizune.co/investors/profile/davide-turco | | Domenico Laudonia | Venture Partner | https://shizune.co/investors/profile/domenico-laudonia | ## Similar investors ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund ## FAQ ### What does Davide Turco invest in? Davide Turco invests primarily in Biotechnology, Hardware and Hospital startups, most often at Seed and Series B stage. Most of the 13 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### When did Davide Turco last invest? The most recent investment recorded for Davide Turco closed in Feb 2025. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co